In a world where most companies seem to be cutting jobs, one company is looking to up their ranks by 25%. MedImmune announced today that they are looking to fill more than 800 positions in research and development and the clinic. AstraZeneca acquired MedImmune in 2007, and since then the latter company is doubling their pipeline in order to represent a quarter of Astra's projects. The recent acquisition may be a boon to MedImmune employees: AstraZeneca ranked at number two of best large companies to work for in our annual linkurl:Best Places to Work: Industry; survey.

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?